ArticleBioengineering (Basel, Switzerland)2026
XAI-MedNet: A Next-Generation Explainable AI Framework for Contrast-Enhanced Skin Lesion Classification via Entropy-Controlled Optimization.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Explainable Artificial Intelligence (XAI) has become a critical requirement in medical image analysis, where transparency and interpretability are essential for clinical trust and decision support. Melanoma is recognized as one of the most deadly types of skin cancer, with its occurrence exhibiting an increasing pattern in recent times. However, detecting this cancer in its initial stages greatly increases patients' chances of long-term survival. Various computer-based techniques have recently been proposed to diagnose skin lesions at their early stages. Even though the machine learning community has achieved a certain degree of success, there is still an unresolved research challenge regarding high error margins and the limited interpretability of automated systems. This study focuses on addressing both segmentation and classification tasks, with particular emphasis on two key concepts: (1) improving image quality to maximize distinguishability between foreground and background regions, thereby enhancing visual interpretability and segmentation accuracy and (2) eliminating redundant and cluttered feature information to generate the most discriminative and compact feature representations. The input images are initially processed using a novel metaheuristic contrast-stretching method to estimate image-specific key parameters, thereby enhancing lesion boundary clarity in a clinically interpretable manner. Following this, the improved images are fed into selected pre-trained deep models, including DenseNet-201, Inception-ResNet v2, and NASNet-Mobile. The extracted features from all pre-trained models are fused to produce resultant vectors, which are then refined using a bio-inspired feature selection method, termed entropy-controlled whale optimization, to retain only the most informative attributes. The selected discriminative feature set is subsequently classified using multiple classifiers. The results indicate that the proposed framework achieves superior performance compared to existing methods in terms of accuracy, sensitivity, specificity, and F1-score. Additionally, it facilitates a more explainable, transparent, and structured diagnostic pipeline appropriate for medical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.